Entry |
|
Symbol |
IKBKB
|
Name |
(RefSeq) inhibitor of nuclear factor kappa-B kinase subunit beta isoform X1
|
KO |
K07209 | inhibitor of nuclear factor kappa-B kinase subunit beta [EC:2.7.11.10] |
|
Organism |
pbrv Petaurus breviceps papuanus (sugar glider)
|
Pathway |
pbrv04620 | Toll-like receptor signaling pathway |
pbrv04621 | NOD-like receptor signaling pathway |
pbrv04622 | RIG-I-like receptor signaling pathway |
pbrv04625 | C-type lectin receptor signaling pathway |
pbrv05166 | Human T-cell leukemia virus 1 infection |
pbrv05167 | Kaposi sarcoma-associated herpesvirus infection |
pbrv05170 | Human immunodeficiency virus 1 infection |
pbrv05208 | Chemical carcinogenesis - reactive oxygen species |
pbrv05235 | PD-L1 expression and PD-1 checkpoint pathway in cancer |
pbrv05418 | Fluid shear stress and atherosclerosis |
|
Brite |
KEGG Orthology (KO) [BR:pbrv00001]
09130 Environmental Information Processing
09132 Signal transduction
04010 MAPK signaling pathway
138152084 (IKBKB)
04014 Ras signaling pathway
138152084 (IKBKB)
04064 NF-kappa B signaling pathway
138152084 (IKBKB)
04668 TNF signaling pathway
138152084 (IKBKB)
04068 FoxO signaling pathway
138152084 (IKBKB)
04151 PI3K-Akt signaling pathway
138152084 (IKBKB)
04150 mTOR signaling pathway
138152084 (IKBKB)
09140 Cellular Processes
09143 Cell growth and death
04210 Apoptosis
138152084 (IKBKB)
09150 Organismal Systems
09151 Immune system
04620 Toll-like receptor signaling pathway
138152084 (IKBKB)
04621 NOD-like receptor signaling pathway
138152084 (IKBKB)
04622 RIG-I-like receptor signaling pathway
138152084 (IKBKB)
04623 Cytosolic DNA-sensing pathway
138152084 (IKBKB)
04625 C-type lectin receptor signaling pathway
138152084 (IKBKB)
04660 T cell receptor signaling pathway
138152084 (IKBKB)
04658 Th1 and Th2 cell differentiation
138152084 (IKBKB)
04659 Th17 cell differentiation
138152084 (IKBKB)
04657 IL-17 signaling pathway
138152084 (IKBKB)
04662 B cell receptor signaling pathway
138152084 (IKBKB)
04062 Chemokine signaling pathway
138152084 (IKBKB)
09152 Endocrine system
04910 Insulin signaling pathway
138152084 (IKBKB)
04920 Adipocytokine signaling pathway
138152084 (IKBKB)
09156 Nervous system
04722 Neurotrophin signaling pathway
138152084 (IKBKB)
09158 Development and regeneration
04380 Osteoclast differentiation
138152084 (IKBKB)
09160 Human Diseases
09161 Cancer: overview
05200 Pathways in cancer
138152084 (IKBKB)
05206 MicroRNAs in cancer
138152084 (IKBKB)
05208 Chemical carcinogenesis - reactive oxygen species
138152084 (IKBKB)
05235 PD-L1 expression and PD-1 checkpoint pathway in cancer
138152084 (IKBKB)
09162 Cancer: specific types
05212 Pancreatic cancer
138152084 (IKBKB)
05221 Acute myeloid leukemia
138152084 (IKBKB)
05220 Chronic myeloid leukemia
138152084 (IKBKB)
05215 Prostate cancer
138152084 (IKBKB)
05222 Small cell lung cancer
138152084 (IKBKB)
09172 Infectious disease: viral
05166 Human T-cell leukemia virus 1 infection
138152084 (IKBKB)
05170 Human immunodeficiency virus 1 infection
138152084 (IKBKB)
05161 Hepatitis B
138152084 (IKBKB)
05160 Hepatitis C
138152084 (IKBKB)
05171 Coronavirus disease - COVID-19
138152084 (IKBKB)
05164 Influenza A
138152084 (IKBKB)
05162 Measles
138152084 (IKBKB)
05168 Herpes simplex virus 1 infection
138152084 (IKBKB)
05163 Human cytomegalovirus infection
138152084 (IKBKB)
05167 Kaposi sarcoma-associated herpesvirus infection
138152084 (IKBKB)
05169 Epstein-Barr virus infection
138152084 (IKBKB)
05165 Human papillomavirus infection
138152084 (IKBKB)
09171 Infectious disease: bacterial
05132 Salmonella infection
138152084 (IKBKB)
05135 Yersinia infection
138152084 (IKBKB)
09174 Infectious disease: parasitic
05145 Toxoplasmosis
138152084 (IKBKB)
05142 Chagas disease
138152084 (IKBKB)
09164 Neurodegenerative disease
05010 Alzheimer disease
138152084 (IKBKB)
09166 Cardiovascular disease
05417 Lipid and atherosclerosis
138152084 (IKBKB)
05418 Fluid shear stress and atherosclerosis
138152084 (IKBKB)
09167 Endocrine and metabolic disease
04930 Type II diabetes mellitus
138152084 (IKBKB)
04936 Alcoholic liver disease
138152084 (IKBKB)
04932 Non-alcoholic fatty liver disease
138152084 (IKBKB)
04931 Insulin resistance
138152084 (IKBKB)
09176 Drug resistance: antineoplastic
01523 Antifolate resistance
138152084 (IKBKB)
09180 Brite Hierarchies
09181 Protein families: metabolism
01001 Protein kinases [BR:pbrv01001]
138152084 (IKBKB)
Enzymes [BR:pbrv01000]
2. Transferases
2.7 Transferring phosphorus-containing groups
2.7.11 Protein-serine/threonine kinases
2.7.11.10 IkappaB kinase
138152084 (IKBKB)
Protein kinases [BR:pbrv01001]
Serine/threonine kinases: Other
IKK family [OT]
138152084 (IKBKB)
|
SSDB |
|
Motif |
|
Other DBs |
|
LinkDB |
|
Position |
Unknown
|
AA seq |
762 aa
MSWPPSLQMQTCGPWEMKERLGTGGFGNVIRWHNEETGEQIAIKQCRQELSLRNRERWCL
EIQIMRRLNHPNVVAARDVPEGMQKLAPNDLPLLAMEYCQGGDLRKYLNQFENCCGLREE
AVLTLLSDIASALRYLHENRIIHRDLKPENIVLQQGEKRLIHKIIDLGYAKELDQGSLCT
SFVGTLQYLAPELLEQQKYTVTVDYWSFGTLAFECITGFRPFLPNWQPVQWHSKVRQKSE
LDIVVSEDLAGGVKFSSSLPYPNNLNSVLVQRLEKWLQLMLMWQPRQRGTDPTYGPNGCF
KALDDILNLKLVHILNMVTGTMYTYPIMEKESLQSLKARIQADTGIPEEDQELLQEAGLA
LFSDKPATQCIVDGKLNDDRILDTDLIFLFDNRKITYETQISPRPPPESVSCILQEPKRN
LPFFQLRKVWGQVWHTIRTLKEDCSQLQQGQRAAMMNLLRNNSSLSKMKNLMASMSQQLK
AKLDFFKTSIQIDLEKYSEQTEFGITSDKLLLAWREMEQTVELCGRHYFYQEIDVKHLVE
QMMALQTDIVDLQRSPMSRKQGGTLDDLEEQARELYRRLREKPRDQRTDGDSQEMVRLLL
QAIQSFEKKVRAIYMQLSKTMVCKQKALELLPQVEEVVNLMNEDEKTVVQLQEKRQKELW
NLLKIACSKVRGPVSGSPDSMNASRLSNPSQLLSQPPAAPYSLPESIKKSEELVMETQTL
CTQLQNVMEDTMRKQDQSFMTLDWTWLQSEDGEQTGVEQTQI |
NT seq |
2289 nt +upstreamnt +downstreamnt
atgagctggccaccttcccttcaaatgcagacttgtgggccctgggaaatgaaagaaagg
cttggaactgggggatttggaaacgtcatccggtggcacaatgaggaaacaggagagcag
atcgccatcaaacagtgccggcaggagctaagtcttcggaatcgagagaggtggtgccta
gaaatacagatcatgagaagactcaaccatcccaatgtagtggctgcccgggatgtccct
gaaggaatgcagaagctggcgcccaatgaccttcctctgctggctatggaatattgccag
ggtggagacctccgaaagtacctgaaccagtttgaaaactgctgtggcctccgggaagaa
gctgttctcactctgctttctgacattgcctcggcacttagataccttcatgaaaaccga
atcatccatcgggacctgaagcctgaaaacatcgtcctgcaacaaggagaaaaaaggtta
atacacaagataattgacctaggatatgccaaagagctggatcaaggcagtctttgcact
tcctttgtggggacgctgcagtacctggctccagagctgttggaacaacagaagtatacg
gttactgtggactattggagctttgggaccctggcctttgagtgtatcacagggttcagg
ccattcctccccaactggcagccagtgcagtggcattcaaaagttcgacagaagagtgaa
ctagatatcgttgttagtgaagacttggctggaggggtgaaattctcaagcagtttacca
taccctaataaccttaacagtgttctagtacagcgtctagaaaagtggctgcagttgatg
ttaatgtggcagccccgacagaggggcacggaccccacttacggcccgaatggctgtttc
aaagcactggacgatatcttgaacctaaagctggttcacatcttgaatatggtaactggc
actatgtacacctatcccatcatggagaaggaaagcttgcaaagcttgaaggccaggatc
caggcagacaccggcatcccagaggaggaccaggagctcttgcaggaggcaggcctggcc
ttgttttctgacaaaccagccacacagtgtattgtggatggcaagctaaatgatgaccga
atattggacacggatctcatttttctctttgacaacagaaaaatcacttatgagactcag
atctccccgaggcccccaccagaaagcgtcagctgtatccttcaagaacccaagaggaat
ctcccatttttccagctgaggaaagtgtggggtcaggtgtggcacacgatccggaccctg
aaggaagactgtagccagctacagcaaggccaaagagctgctatgatgaacctgcttcga
aataacagcagcctctccaaaatgaagaacctaatggcctccatgtcccagcagctcaag
gccaagctggatttctttaaaaccagcatccagattgacctggagaagtacagcgagcag
accgagtttggcatcacgtcagataagctgctgttggcctggcgggagatggagcaaacc
gtggagctctgtgggcggcactatttttatcaggagatagatgtgaaacatctggtggaa
cagatgatggccctgcagacagatatcgtggacctacagaggagcccaatgagtcggaaa
caagggggaactttggacgatctagaagaacaagcaagagagctttatcggcgattaagg
gaaaaaccaagagaccagcgaactgatggcgacagtcaagaaatggttcggttactcctt
caggccatccagagctttgagaagaaagtacgagccatttatatgcagctcagtaaaact
atggtttgcaagcagaaggccctggaattgttacctcaagtggaagaagtggtgaactta
atgaacgaagatgagaagacagtcgtgcagctccaggagaaaagacagaaggagctttgg
aatctcctgaagatcgcttgtagcaaagtacgaggtccagtgagtgggagtccagatagc
atgaatgcatctcgtcttagtaatccttcccagttgttatctcaacctcccgcagctccc
tacagcttacctgagtcaatcaagaaaagtgaagaactggtaatggaaacacagaccctc
tgcacccagttacaaaatgtaatggaggacaccatgagaaagcaagatcagagtttcatg
accctggactggacctggttacagtctgaggatggagaacagaccggtgtggagcagacg
cagatctga |